ACM
BSX icon

Atika Capital Management’s Boston Scientific BSX Stock Holding History

Atika Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-85,200
Closed -$7.61M – 67
2024
Q4 		$7.61M Buy
+85,200
New +$7.5M 0.81% 39
2024
Q3 		– Sell
-101,000
Closed -$7.78M – 89
2024
Q2 		$7.78M Buy
+101,000
New +$7.39M 0.76% 45
2016
Q3 		– Sell
-64,000
Closed -$1.5M – 68
2016
Q2 		$1.5M Buy
+64,000
New +$1.38M 0.64% 47

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Atika Capital Management's BSX Position: Q1 2025 in Review

Atika Capital Management sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 85,200 shares — an estimated $7.61M sold.

Atika Capital Management first reported a position in BSX in Q2 2016 and held it in 3 quarters. The position peaked at $7.78M in Q2 2024. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Atika Capital Management reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
  • Atika Capital Management sold 85,200 Boston Scientific shares in Q1 2025, an estimated $7.61M.
  • Atika Capital Management first reported a position in Boston Scientific in Q2 2016 and held it in 3 quarters.
  • Atika Capital Management's Boston Scientific position peaked at $7.78M in Q2 2024.
  • 1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Atika Capital Management's 13F filing for Q1 2025, filed 14 May 2025.